Cell lines transfected with the TAP inhibitor ICP47 allow testing peptide binding to a variety of HLA class I molecules

International Immunology

Volumn 10, Issue 11, 1998, Pages 1665-1672

  Gatfield, John ^a   Lammert, Eckhard ^a   Nickolaus, Peter ^a   Münz, Christian ^a   Rothenfusser, Simon ^b   Fisch, Paul ^a   Stevanović, Stefan ^a   Schild, Hansjörg ^a   Rammensee, Hans Georg ^a   Arnold, Danièle ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

HLA class I ligands; HLA class I motifs; HLA class I surface expression

Indexed keywords

COMPLEMENTARY DNA; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; IMMEDIATE EARLY PROTEIN; LEUKOCYTE ANTIGEN; LIGAND; PEPTIDE;

ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL;

ALLELES; AMINO ACID SEQUENCE; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE; FEMALE; FLOW CYTOMETRY; HERPESVIRUS 2, HUMAN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-A ANTIGENS; HLA-B ANTIGENS; HUMANS; IMMEDIATE-EARLY PROTEINS; LIGANDS; MICE; OLIGOPEPTIDES; SEQUENCE ALIGNMENT; TRANSFECTION; VIRAL PROTEINS;

EID: 7844247936     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/10.11.1665     Document Type: Article

References (29)

1. Falk, K., Rötzschke, O., Stevanović, S., Jung, G. and Rammensee, H.-G. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290.
2. Rammensee, H.-G., Bachmann, J. and Stevanović, S. 1997. WHC Ligands and Peptide Motifs. Landes Bioscience, Georgetown, TX.
3. Joyce, S. and Nathenson, S. G. 1994. Methods to study peptides associated with MHC class I molecules. Curr. Opin. Immunol. 6:24.
4. d-restricted antigenic peptides share a simple binding motif. J. Exp. Med. 174:603.
5. Stuber, G., Modrow, S., Hoglund, P., Franksson, L., Elvin, J., Wolf, H., Kärre, K. and Klein, G. 1992. Assessment of major histocompatibility complex class I interaction with Epstein-Barr virus and human immunodeficiency virus peptides by elevation of membrane H-2 and HLA in peptide loading-deficient cells. Eur. J. Immunol. 22:2697.
6. Sugawara, S., Abo, T. and Kumagai, K. 1987. A simple method to eliminate the antigenicity of surface class I MHC molecules from the membrane of viable cells by acid treatment at pH 3. J. Immunol. Methods 100:83.
7. Zeh, H. I. I., Leder, G., Lotze, M., Salter, R., Tector, M., Stuber, G., Modrow, S. and Storkus, W. 1994. Flow-cytometric determination of peptide-class I complex formation: identification of p53 peptides that bind to HLA-A2. Hum. Immunol. 39:79.
8. DeMars, R., Chang, C. C., Shaw, S., Reitnauer, P. J. and Sondel, P. M. 1984. Homozygous deletions that simultaneously eliminate expressions of class I and class Il antigens of EBV-transformed B-lymphoblastoid cells. I. Reduced proliferative responses of autologous and allogeneic T cells to mutant cells that have decreased expression of class II antigens. Hum. Immunol. 11:77.
9. Salter, R. D., Howell, D. N. and Cresswell, P. 1985. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics 21:235.
10. de la Salle, H., Hanau, D., Fricker, D., Urlacher, A., Kelly, A., Salamero, J., Powis, S. H., Donato, L., Bausinger, H., Laforet, M., Jeras, M., Spehner, D., Bieber, T., Falkenrodt, A., Cazenave, J.-P., Trowsdale, J. and Tongio, M.-M. 1994. Homozygous human TAP peptide transporter mutation in HLA class I deficiency. Science 265:237.
11. Ljunggren, H. G. and Kärre, K. 1985. Host resistance directed selectively against H-2- deficient lymphoma variants. Analysis of the mechanism. J. Exp. Med. 162:1745.
12. Ibe, M., Moore, Y. I., Miwa, K., Kaneko, Y., Yokota, S. and Takiguchi, M. 1996. Role of strong anchor residues in the effective binding of 10-mer and 11-mer peptides to HLA-A*2402 molecules. Immunogenetics 44:233.
13. Hill, A., Jugovic, P., York, I., Russ, G., Bennink, J., Yewdell, J., Ploegh, H. and Johnson, D. 1995. Herpes simplex virus turns off the TAP to evade host immunity. Nature 375:411.
14. Früh, K., Ahn, K., Djaballah, H., Sempe, P., van Endert, P. M., Tampé, R., Peterson, P. A. and Yang, Y. 1995. A viral inhibitor of peptide transporters for antigen presentation. Nature 375:415.
15. Zemmour, J., Little, A. M., Schendel, D. J. and Parham, P. 1992. The HLA-A,B 'negative' mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. J. Immunol. 148:1941.
16. Zemmour, J. 1996. Inefficient assembly limits transport and cell surface expression of HLA-Cw4 molecules in C1R. Tissue Antigens 48:651.
17. Barnstable, C. J., Bodmer, W. F., Brown, G., Galfre, G., Milstein, C., Williams, A. F. and Ziegler, A. 1978. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell 14:9.
18. 2-terminal 35 residues. J. Exp. Med. 185:1565.
19. Ahn, K., Meyer, T. H., Uebel, S., Sempe, P., Djaballah, H., Yang, Y., Peterson, P.A., Früh, K. and Tampé, R. 1996. Molecular mechanism and species specificity of TAP inhibition by herpes Simplex virus ICP47. EMBO J. 15:3247.
20. Androlewicz, M. J., Anderson, K. S. and Cresswell, P. 1993. Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner. Proc. Natl Acad. Sci. USA 90:9130.
21. Neefjes, J. J., Momburg, F. and Hämmerling, G. J. 1993. Selective and ATP- dependent translocation of peptides by the MHC-encoded transporter. Science 261:769.
22. Lin, A. Y., Devaux, B., Green, A., Sagerstrom, C., Elliott, J. F. and Davis, M. M. 1990. Expression of T cell antigen receptor heterodimers in a lipid-linked form. Science 249:677.
23. Browning, M. J., Madrigal, J. A., Krausa, P., Kowalski, H., Allsopp, C. E., Little, A. M., Turner, S., Adams, E. J., Arnett, K. L., Bodmer, W. F., Bodmer, J. G. and Parham, P. 1995. The HLA-A,B,C genotype of the class I negative cell line Daudi reveals novel HLA-A and -B alleles. Tissue Antigens 45:177.
24. Falk, K., Rötzschke, O., Takiguchi, M., Grahovac, B., Gnau, V., Stevanović, S., Jung, G. and Rammensee, H.-G. 1994. Peptide motifs of HLA-A1, -A11, -A31, and -A33 molecules. Immunogenetics 40:238.
25. Seeger, F. H., Arnold, D., Dumrese, T., de la Salle, H., Fricker, D., Schild, H., Rammensee, H.-G. and Stevanović, S. 1998. The HLA-B*1516 motif indicates HLA- B specific P2 pocket characteristics. Immunogenetics 48:156.
26. Lammert, E., Stevanović, S., Brunner, J., Rammensee, H. G. and Schild, H. 1997. Protein disulfide isomerase is the dominant acceptor for peptides translocated into the endoplasmic reticulum. Eur. J. Immunol. 27:1685.
27. Rötzschke, O., Falk, K., Stevanović, S., Gnau, V., Jung, G. and Rammensee, H.-G. 1994. Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs. Immunogenetics 39:74.
28. Wei, M. L. and Cresswell, P. 1992. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature 356:443.
29. Ruppert, J., Sidney, J., Celis, E., Kubo, R. T., Grey, H. M. and Sette, A. 1993. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 74:929.